August 16, 2025

Successful tocilizumab monotherapy for multicentric Castleman disease complicated by rheumatoid arthritis and Sjögren's disease: a case-based literature review.

View Full Paper

Ask AI

Bookmark

Tocilizumab monotherapy led to successful treatment outcomes in a patient with multicentric castleman disease.
Three cases of patients with multicentric castleman disease and autoimmune conditions responded well to tocilizumab.
The therapeutic approach highlights the effectiveness of IL-6 receptor antagonists in complex disorders.
Findings suggest tocilizumab may provide new hope for managing challenging autoimmune disease scenarios.

Authors

Discussion

No takes yet. Share an insight, caveat, or question.

Case report shows favorable outcomes using tocilizumab in multicentric castleman disease, suggesting its role in autoimmune disorders.

Suzuki et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark